TY - JOUR
KW - buprenorphine
KW - California State Targeted Response
KW - Hub and spoke
KW - Medications for opioid use disorders
KW - Opioid
AU - K. Darfler
AU - J. Sandoval
AU - Pearce Antonini
AU - D. Urada
A1 - 
AD - University of California, Los Angeles Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd, Los Angeles, CA 90025, United States of America. Electronic address: kdarfler@mednet.ucla.edu.; University of California, Los Angeles Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, United States of America. Electronic address: josesandoval@mednet.ucla.edu.; University of California, Los Angeles Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, United States of America. Electronic address: vpearce@mednet.ucla.edu.; University of California, Los Angeles Integrated Substance Abuse Programs, David Geffen School of Medicine at UCLA, United States of America. Electronic address: durada@mednet.ucla.edu.
BT - Journal of substance abuse treatment
C5 - Opioids & Substance Use
CY - United States
JF - Journal of substance abuse treatment
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2020
SN - 1873-6483; 0740-5472
SP - 26
EP - 32
EP - 
T1 - Preliminary results of the evaluation of the California Hub and Spoke Program
T2 - Journal of substance abuse treatment
TI - Preliminary results of the evaluation of the California Hub and Spoke Program
U1 - Opioids & Substance Use
U2 - 31400985
VL - 108
VO - 1873-6483; 0740-5472
Y1 - 2020
Y2 - Jan
ER -